David Araujo-Vilar
Overview
Explore the profile of David Araujo-Vilar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cobelo-Gomez S, Sanchez-Iglesias S, Rabano A, Senra A, Aguiar P, Gomez-Lado N, et al.
Neurobiol Dis
. 2023 Sep;
187:106300.
PMID: 37717662
Celia's encephalopathy or progressive encephalopathy with/without lipodystrophy is a neurodegenerative disease with a fatal prognosis in childhood. It is generally caused by the c.985C > T variant in the BSCL2...
12.
Fernandez-Crespo S, Vazquez-Agra N, Marques-Afonso A, Cruces-Sande A, Martinez-Olmos M, Araujo-Vilar D, et al.
Med Clin (Barc)
. 2023 Aug;
161(11):470-475.
PMID: 37541939
Background And Aims: We aimed to evaluate the differences in some cardiovascular risk (CVR) factors between adult patients without and with phenylketonuria (PKU) and to explore the correlation between waist...
13.
Haymond M, Araujo-Vilar D, Balser J, Lewis J, Louzado R, Musso C, et al.
Orphanet J Rare Dis
. 2023 May;
18(1):127.
PMID: 37237416
Background: Metreleptin, a recombinant analog of human leptin, is an approved therapy, adjunct to diet, to treat the metabolic complications of leptin deficiency in patients with lipodystrophy - a group...
14.
Araujo-Vilar D, Fernandez-Pombo A, Cobelo-Gomez S, Castro A, Sanchez-Iglesias S
Endocrinol Diabetes Nutr (Engl Ed)
. 2023 Apr;
70(4):290-292.
PMID: 37116975
No abstract available.
15.
Fernandez-Pombo A, Diaz-Lopez E, Castro A, Sanchez-Iglesias S, Cobelo-Gomez S, Prado-Morana T, et al.
Cells
. 2023 Mar;
12(5).
PMID: 36899861
Type 2 familial partial lipodystrophy (FPLD2) is a laminopathic lipodystrophy due to pathogenic variants in the gene. Its rarity implies that it is not well-known. The aim of this review...
16.
Costa-Lathan C, Vazquez-Agra N, Marques-Afonso A, Cruces-Sande A, Martinez-Olmos M, Araujo-Vilar D, et al.
J Investig Med
. 2023 Jan;
71(2):149-158.
PMID: 36647337
We aimed to evaluate the role of plasma phenylalanine (Phe) levels and its fluctuations in some neurocognitive domains and brain magnetic resonance imaging (MRI) findings in adult patients with phenylketonuria...
17.
Mosbah H, Akinci B, Araujo-Vilar D, Carrion Tudela J, Ceccarini G, Collas P, et al.
Ann Endocrinol (Paris)
. 2022 Oct;
83(6):461-468.
PMID: 36206842
Lipodystrophy syndromes are rare diseases with defects in the development or maintenance of adipose tissue, frequently leading to severe metabolic complications. They may be genetic or acquired, with variable clinical...
18.
Araujo-Vilar D, Fernandez-Pombo A, Cobelo-Gomez S, Castro A, Sanchez-Iglesias S
Hormones (Athens)
. 2022 Jul;
21(4):555-571.
PMID: 35835948
With the exception of HIV-associated lipodystrophy, lipodystrophy syndromes are rare conditions characterized by a lack of adipose tissue, which is not generally recovered. As a consequence, an ectopic deposition of...
19.
Corvillo F, Abel B, Lopez-Lera A, Ceccarini G, Magno S, Santini F, et al.
Diabetes
. 2022 Jun;
72(1):71-84.
PMID: 35771980
Acquired generalized lipodystrophy (AGL) is a rare condition characterized by massive loss of adipose tissue through the body, causing severe metabolic complications. Autoimmune destruction of adipocytes is strongly suspected based...
20.
Fernandez-Pombo A, Sanchez-Iglesias S, Cobelo-Gomez S, Hermida-Ameijeiras A, Araujo-Vilar D
Presse Med
. 2021 Oct;
50(3):104071.
PMID: 34610417
Lipodystrophies are a heterogeneous group of rare conditions characterised by the loss of adipose tissue. The most common forms are the familial partial lipodystrophy (FPLD) syndromes, which include a set...